Market Overview

Cantor Fitzgerald Reiterates Hold, $29 PT on Centene Amid Challenges

Related CNC
Updated Research Report on Health Net - Analyst Blog
Morgan Stanley Sees Centene as Aiming for Execution in 2014

Cantor Fitzgerald reiterates its Hold rating and $29 price target on Centene (NYSE: CNC) on lack of visibility amid challenges emanating from the company's recent earnings shortfall.

Cantor Fitzgerald comments, "Centene used today's Investor Day to add detail regarding Monday's announcement of a big earnings shortfall and to lay out its action plan. Significant steps are being taking at each of the company's affected businesses, and it is reviewing Celtic, but while it appears confident that these problems will be resolved, the path is neither simple nor obviously developed according to a specific timeline. We like the detailed analysis of the problem and the plan, but prefer to at least wait for the 2Q:12 earnings call (and an update) before stepping up to the stock."

CNC closed at $28.20 on Thursday.

Posted-In: Cantor FitzgeraldAnalyst Color Price Target Reiteration Pre-Market Outlook Analyst Ratings

 

Most Popular

Related Articles (CNC)

Around the Web, We're Loving...

Partner Network

Get Benzinga's News Delivered Free